Stockreport

Pacira Announces Topline Phase 3 Results for EXPAREL® as a Single-dose Nerve Block

Pacira BioSciences, Inc.  (PCRX) 
Last pacira biosciences, inc. earnings: 2/20 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.pacira.com
PDF Upper extremity study showed that EXPAREL significantly reduces pain scores and opioid use Lower extremity study defined safety and pharmacokinetic profile through 120 [Read more]